Adhesion Barrier Market - Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2022 - 2027

Report Code: HCR 0533 Report Format: PDF + Excel (Delivery in 48 Hrs)

Adhesion Barrier Market Overview

The Adhesion Barrier market size is estimated to reach $885 million by 2027, growing at a CAGR of 7.3% during the forecast period 2022-2027. An adhesion barrier is a medical implant that helps restrict abnormal internal scarring after surgical procedures. The implant allows for the separation of internal tissues and organs while healing. Once the healing process is complete, the barrier will safely dissolve away. Adhesion Barrier products can either be synthetic, such as Hyaluronic Acid, Regenerated Cellulose, and Polyethylene Glycol, or Natural barriers such as Fibrin, Protein, and Collagen. The rapid global rise in the geriatric population is anticipated to drive the Adhesion Barrier Market during the forecast period 2022-2027. However, the various drawbacks and low frequency of their use during surgical procedures act as a key challenge for the Adhesion Barrier industry.

Report Coverage

The report: “Adhesion Barrier Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Adhesion Barrier Market.

By Product Type: Synthetic Adhesion Barriers, Natural Adhesion Barriers.
By Formulation: Film Formulation, Gel Formulation, and Liquid Formulation.
By Application: Cardiovascular Surgeries, General/Abdominal Surgeries, Gynecological Surgeries, Neurological Surgeries, Orthopedic Surgeries, Reconstructive Surgeries, Urological Surgeries, and Other Surgeries.
By End User: Hospitals, Clinics, Ambulatory Surgical Centers, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa). 

Key Takeaways

  • Geographically, the North American Adhesion Barrier market accounted for the largest share in 2021 owing to the favorable reimbursement policies for Adhesion Barriers in the region.
  • An increase in awareness levels regarding the importance and applications of Adhesion barriers in developing regions is driving the market. However, the high cost of surgical procedures in the US is challenging demand generation during the forecast period.
  • Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Adhesion Barrier Market Report.

Adhesion Barrier Market Share, By Geography, 2021(%)

Adhesion Barrier Market Share

For More Details on This Report - Request for Sample

Adhesion Barrier Market Segment Analysis - By Applications

Based on Application, the Adhesion Barrier Market is segmented into Cardiovascular Surgeries, General/Abdominal Surgeries, Gynecological Surgeries, Neurological Surgeries, Orthopedic Surgeries, Reconstructive Surgeries, Urological Surgeries, and Other Surgeries. The Gynecological Surgeries segment is anticipated to have the largest share of the market in 2021 and is poised to dominate the market during the forecast period 2022-2027. This is attributed to the rise in the number of gynecologic laparoscopy procedures, ovarian cystectomies, pelvic surgeries, and laparotomy procedures. Adhesion barriers help reduce the risk of developing clinically significant adhesions, especially among patients who have endometriosis/pelvic inflammatory disease or are undergoing a myomectomy. The Cardiovascular Surgeries segment is projected to grow the fastest at a CAGR of 7.7% owing to the global increase in cardiovascular diseases, and risk factors such as diabetes, obesity, and hypertension.

Adhesion Barrier Market Segment Analysis - By End User

The Adhesion Barrier Market based on End User can be further segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. The Hospitals segment accounted for the largest share of the market in 2021. This can be attributed to the presence of multiple specialized departments and highly experienced surgeons in hospitals. This enables them to provide superior care to a large number of patients simultaneously. Moreover, hospitals can provide all the essential services such as screening, diagnosis, consultation, surgery, and post-surgery therapy in one location, thereby increasing convenience and reducing costs. However, the Ambulatory Surgical Centers segment is also anticipated to witness a significant CAGR of 7.9% during the forecast period owing to their lower surgery costs. These facilities are focused on providing same-day surgical care and therefore, they are an attractive choice for minor surgeries that do not require long-term hospitalizations.

Adhesion Barrier Market Segment Analysis - By Geography

The Adhesion Barrier Market based on Geography can be segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. The North American segment is projected to dominate the Adhesion Barrier market during the forecast period 2022-2027 with a market share of 32% owing to the presence of a highly developed healthcare infrastructure, favorable reimbursement policies for Adhesion Barriers, high patient awareness levels, and growing geriatric population in the region. Moreover, the rapid rise in lifestyle diseases and cancer in North America is another major factor contributing to its growth. The Asia Pacific region is predicted to register the fastest growth owing to the increase in disposable income, rising healthcare infrastructure development, and growing public healthcare funding in major emerging economies like China and India.

Adhesion Barrier Market Drivers

An Increase in Geriatric Population is Projected to Drive Adhesion Barrier Market Growth

There were around 727 million persons over the age of 65 in 2020 and constituted 9.3% of the overall population. The geriatric population is predicted to reach 16% by 2050. This is anticipated to drive the market during the forecast period as the geriatric population is more prone to diseases such as cardiovascular disorders, cancers, orthopedic diseases, and neurological conditions. For instance, the average age of heart attack in the US is 74.5 for men and 78.9 for women. Meanwhile, the average age of prostate cancer diagnosis is around 66. This is increasing the number of surgeries performed for treatment and thereby, generating demand for Adhesion Barriers.

The rise in Lifestyle disorders is Anticipated to Boost Product Demand

Owing to the growth in global disposable income and urbanization, more people are following a sedentary lifestyle. This is causing an increase in lifestyle diseases such as obesity, hypertension, cancers, and diabetes. Around 39% of the global adult population is overweight and 9.8% suffer from diabetes. According to the World Health Organization (WHO), diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower-limb amputations. Furthermore, 26% of the population suffers from hypertension and this is projected to reach 29% by 2025. The growth of such disorders is increasing the prevalence of diseases such as cancer, stroke, and heart failure among young adults, which is driving the demand for Adhesion Barriers.

Adhesion Barrier Market Challenges

The High Cost of Surgery is Anticipated to Hamper the Growth of Adhesion Barrier Market

The high surgery costs charged by healthcare facilities in developed regions such as the US is hampering growth opportunities. For instance, heart bypass surgery can cost around $70,000 to $200,000 or more, and heart transplant surgery can reach around $800,000. Moreover, for patients not covered by health insurance, brain surgery procedures can cost between $50,000 and $150,000 or more. This is a major challenge owing to the fact that the median household income of the US is only $67,521, making these procedures unaffordable to the majority of the population. According to the American Journal of Public Health, around 66.5% of bankruptcies in the US occurred due to high medical expenses.

Rising Demand for Minimally Invasive Surgeries is Projected to Limit Growth Opportunities

The rising global popularity of minimally invasive surgeries is having a negative impact on Adhesion Barriers. As they were designed 2 or 3 decades ago, Adhesion Barriers were meant to be used during open surgery. However, this also made most of them unsuitable to be used during modern minimally invasive surgical procedures. Moreover, minimally invasive surgeries significantly reduce internal tissue scarring, which eliminates the need for Adhesion Barriers. These limitations and the disregard for requiring barriers in minimally invasive surgery have impeded research and development of barriers suitable for minimally invasive surgery. Only around 1 in 7 surgeons use Adhesion Barriers during their surgical procedures as most believe they are unnecessary and expensive. 

Adhesion Barrier Market Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Adhesion Barrier Market. The top 10 companies of the industry include:

  1. Sanofi
  2. Baxter International
  3. Johnson & Johnson
  4. Integra Life Sciences Holdings
  5. C.R. Bard
  6. Anika Therapeutics
  7. Atrium Medical Corporation
  8. FzioMed
  9. Betatech Medical
  10. Innocoll Holdings
Partnerships/Product Launches:

  • In January 2020, Anika Therapeutics announced that they have signed agreements to acquire Parcus Medical, a leading sports medicine company, and Arthrosurface, a leading, provider of the joint surface and preservation solutions for active patients. The acquisitions are expected to drive Anika’s growth by broadening its product portfolio into joint preservation and restoration.
  • In February 2020, Baxter International completed its acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million. The Seprafilm product family is used as an adjunct to reduce the incidence, extent, and severity of adhesions in certain pelvic and abdominal surgeries.

Relevant Links:

Sports Medicine Devices Market - Forecast (2022 - 2027)
Report Code: HCR 0094

Cardiology Surgical & Interventional Cardiology Devices Market - Forecast (2022 - 2027)
Report Code: HCR 0017

For more Lifesciences and Healthcare Market reports, please click here

1. Adhesion Barrier Market - Overview
    1.1 Definitions and Scope
2. Adhesion Barrier Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by End User
    2.4 Key trends by Geography
3. Adhesion Barrier Market – Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis – Average Selling Price
4. Adhesion Barrier Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Adhesion Barrier Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Adhesion Barrier Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Adhesion Barrier Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Adhesion Barrier Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Synthetic Adhesion Barriers
        8.1.1 Hyaluronic Acid
        8.1.2 Regenerated Cellulose
        8.1.3 Polyethylene Glycol
        8.1.4 Other Synthetic Adhesion Barriers
    8.2 Natural Adhesion Barriers
    8.2.1 Collagen & Protein
    8.2.2 Fibrin
9. Adhesion Barrier Market – By Formulation (Market Size –$Million/$Billion)
    9.1 Film Formulation
    9.2 Gel Formulation
    9.3 Liquid Formulation
10. Adhesion Barrier Market – By Application (Market Size –$Million/$Billion)
    10.1 Cardiovascular Surgeries
    10.2 General/Abdominal Surgeries
    10.3 Gynecological Surgeries
    10.4 Neurological Surgeries
    10.5 Orthopedic Surgeries
    10.6 Reconstructive Surgeries
    10.7 Urological Surgeries
    10.8 Other Surgeries
11. Adhesion Barrier Market - By End User (Market Size –$Million/$Billion)
    11.1 Hospitals
    11.2 Clinics
    11.3 Ambulatory Surgical Centers
    11.4 Others
12. Adhesion Barrier Market - By Geography (Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Adhesion Barrier Market - Entropy
14. Adhesion Barrier Market – Industry/Segment Competition Landscape Premium
    14.1 Market Share Analysis
    14.1.1 Global Market Share – Key Companies
    14.1.2 Market Share by Region – Key companies
    14.1.3 Market Share by Countries – Key Companies
    14.1.4 Competition Matrix
    14.1.5 Best Practices for Companies
15. Adhesion Barrier Market – Key Company List by Country Premium Premium
16. Adhesion Barrier Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best-efforts basis”.